We are live on ! Find out more
IA

IFP Advisors Portfolio holdings

AUM $5.54B
1-Year Est. Return 27.43%
This Fund
S&P 500
This Quarter Est. Return
+4.46%
1 Year Est. Return
+27.43%
3 Year Est. Return
+73.16%
5 Year Est. Return
+63.71%
10 Year Est. Return
AUM
$2.39B
AUM Growth
+$94.5M
Cap. Flow
-$124M
Cap. Flow %
-5.19%
Top 10 Hldgs %
15.53%
Holding
3,628
New
281
Increased
1,049
Reduced
1,188
Closed
187

Sector Composition

Rank Sector Weight
1 Technology 8.47%
2 Financials 4.06%
3 Consumer Discretionary 3.84%
4 Industrials 3.19%
5 Healthcare 3.13%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ROOT icon
3401
Root
ROOT
$917M
$36 ﹤0.01%
+4
New +$22
SGLY icon
3402
Singularity Future Technology
SGLY
$241K
$36 ﹤0.01%
7
UMI icon
3403
USCF Midstream Energy Income Fund
UMI
$516M
$34 ﹤0.01%
+1
New +$33
BBBY
3404
Bed Bath & Beyond
BBBY
$473M
$33 ﹤0.01%
1
-11
-92% -$203
HIPO icon
3405
Hippo Holdings
HIPO
$723M
$33 ﹤0.01%
2
PDN icon
3406
Invesco FTSE RAFI Developed Markets ex-US Small-Mid ETF
PDN
$349M
$31 ﹤0.01%
1
PXLW icon
3407
Pixelworks
PXLW
$38.8M
$31 ﹤0.01%
+2
New +$39
EXPR
3408
DELISTED
Express, Inc.
EXPR
$30 ﹤0.01%
3
IIGD icon
3409
Invesco Investment Grade Defensive ETF
IIGD
$26.7M
$29 ﹤0.01%
+1
New +$24
RBBN icon
3410
Ribbon Communications
RBBN
$354M
$28 ﹤0.01%
10
SNDL icon
3411
Sundial Growers
SNDL
$325M
$27 ﹤0.01%
+20
New +$30
NVTA
3412
DELISTED
Invitae Corporation
NVTA
$27 ﹤0.01%
24
CRBP icon
3413
Corbus Pharmaceuticals
CRBP
$170M
$24 ﹤0.01%
3
-100
-97% -$899
INDV icon
3414
Indivior Pharmaceuticals
INDV
$4.79B
$24 ﹤0.01%
+1
New +$23
NBSE
3415
DELISTED
NeuBase Therapeutics, Inc. Common Stock
NBSE
$24 ﹤0.01%
+105
New +$346
GOEV
3416
DELISTED
Canoo Inc. Class A Common Stock
GOEV
0
CENN icon
3417
Cenntro
CENN
$8.23M
0
CYTH
3418
DELISTED
Cyclo Therapeutics, Inc. Common Stock
CYTH
$21 ﹤0.01%
13
HARP
3419
DELISTED
Harpoon Therapeutics, Inc. Common Stock
HARP
$21 ﹤0.01%
3
EWH icon
3420
iShares MSCI Hong Kong ETF
EWH
$1.22B
$19 ﹤0.01%
1
NSTB.WS
3421
DELISTED
Northern Star Investment Corp. II Redeemable warrants, each whole warrant exercisable for shares of Class A common stock at an exercise price of $11.50 per share
NSTB.WS
$19 ﹤0.01%
1,000
GNLN icon
3422
Greenlane Holdings
GNLN
$1.33M
0
GTBP icon
3423
GT Biopharma
GTBP
$11.7M
$16 ﹤0.01%
2
SOUN icon
3424
SoundHound AI
SOUN
$2.68B
$14 ﹤0.01%
+3
New +$9
BGRY
3425
DELISTED
Berkshire Grey, Inc. Class A Common Stock
BGRY
$13 ﹤0.01%
+9
New +$12

Similar funds

IFP Advisors's Q2 2023 Portfolio in Review

As of Q2 2023, IFP Advisors held 3,628 positions worth $2.39B, up 4.1% from $2.3B the previous quarter. Its ten largest holdings account for 16% of the portfolio.

IFP Advisors withdrew a net $124M in Q2 2023, closing 187 positions and reducing 1,188 holdings. Its most notable exit was VictoryShares US Discovery Enhanced Volatility Wtd ETF, an estimated $2.33M position sold in full.

By sector, the portfolio is most concentrated in Technology at 8.5% of assets, up from 4.4% a quarter earlier, followed by Financials and Consumer Discretionary.

Against the trend, IFP Advisors opened a new position in Direxion HCM Tactical Enhanced US ETF worth $1.57M.

  • IFP Advisors's largest Q2 2023 buy was Direxion HCM Tactical Enhanced US ETF: 60,519 shares worth $1.57M.
  • IFP Advisors added most to First Trust Enhanced Short Maturity ETF in Q2 2023, an estimated $24.1M increase.
  • IFP Advisors's biggest Q2 2023 reduction was iShares Floating Rate Bond ETF, cutting an estimated $18.3M.
  • IFP Advisors fully exited VictoryShares US Discovery Enhanced Volatility Wtd ETF in Q2 2023, selling an estimated $2.33M.
  • IFP Advisors's ten largest holdings make up 16% of its $2.39B portfolio in Q2 2023.
  • IFP Advisors opened 281 new positions and closed 187 in Q2 2023.
  • IFP Advisors's portfolio value rose 4.1% quarter-over-quarter to $2.39B.

Based on IFP Advisors's 13F filing for Q2 2023, filed 4 Aug 2023.